← Back to Search

PAO With vs Without Arthroscopy for Hip Dysplasia

N/A

Recruiting

Led By Geoffrey Wilkin, MD

Research Sponsored by Ottawa Hospital Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age, 16-50 years old

Skeletally mature patient undergoing Bernese periacetabular osteotomy for symptomatic acetabular dysplasia/hip instability

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2-4 weeks and 3 months after surgery

Awards & highlights

Study Summary

This trial will help determine if performing a hip arthroscopy at the same time as a PAO improves patient outcomes.

Who is the study for?

This trial is for individuals aged 16-50 who can consent to treatment, have mature skeletons, and are undergoing surgery for hip instability due to acetabular dysplasia. They must be able to attend all follow-ups and complete questionnaires. Those with advanced arthritis, cognitive impairments, previous hip surgeries or certain genetic disorders cannot participate.Check my eligibility

What is being tested?

The study aims to determine if adding a hip arthroscopy procedure at the same time as a periacetabular osteotomy (PAO) leads to better outcomes than PAO alone. Patients will be randomly assigned to either just receive PAO or both PAO and hip arthroscopy.See study design

What are the potential side effects?

While specific side effects are not listed here, common risks of surgical procedures like PAO may include pain, bleeding, infection risk post-surgery, possible damage to surrounding tissues or nerves during operation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 16 and 50 years old.

Select...

I am an adult having surgery for hip dysplasia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to one month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to one month

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to one month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

iHOT-33

Secondary outcome measures

Adverse Events

Cost-Effectiveness

HOOS

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PAO with hip arthroscopyExperimental Treatment1 Intervention

Patient's in the "Scope PAO" group have been diagnosed with hip dysplasia and a decision has been made between the patient and the surgeon that the best way to treat the hip problems is with surgery. Patient's in the "Scope-PAO" group have been randomized to receive a periacetabular osteotomy with a hip arthroscopy.

Group II: PAO without hip arthroscopyActive Control1 Intervention

Patient's in the "PAO-only" group have been diagnosed with hip dysplasia and a decision has been made between the patient and the surgeon that the best way to treat the hip problems is with surgery. Patient's in the "PAO-only" group have been randomized to receive a periacetabular osteotomy only.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor

563 Previous Clinical Trials

2,787,510 Total Patients Enrolled

1 Trials studying Hip Dysplasia

58 Patients Enrolled for Hip Dysplasia

Geoffrey Wilkin, MDPrincipal InvestigatorThe Ottawa Hospital Research Institute

Media Library

PAO with hip arthroscopy Clinical Trial Eligibility Overview. Trial Name: NCT03481010 — N/A

Hip Dysplasia Research Study Groups: PAO with hip arthroscopy, PAO without hip arthroscopy

Hip Dysplasia Clinical Trial 2023: PAO with hip arthroscopy Highlights & Side Effects. Trial Name: NCT03481010 — N/A

PAO with hip arthroscopy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03481010 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there multiple locations in the US which are offering this research project?

"The trial is currently being conducted at seven medical centres, such as Ottawa Hospital Research Institute in the capital city of Canada and CHU de Québec - Université Laval in Quebec. Additionally, there are other establishments recruiting participants across the United States, including New york's esteemed Hospital for Special Surgery."

Answered by AI

Are recruitment efforts still ongoing for this research endeavor?

"Clinicaltrials.gov affirms that recruitment for this clinical trial is still ongoing. It first appeared on the site in April 4th, 2018 and was last modified on September 22nd 2022."

Answered by AI

How many test subjects have participated in this research endeavor?

"Indeed, the information located on clinicaltrials.gov reveals that the investigation is presently recruiting participants. This study was initially published April 4th 2018 and revised September 22nd 2022; it seeks to recruit 188 individuals from 7 distinct medical centres."

Answered by AI

Is this clinical investigation open to those of advanced age?

"As specified in the study's criteria, those aged 16 to 50 are allowed to partake."

Answered by AI

Who can qualify to join this medical exploration?

"This medical trial seeks to enlist up to 188 participants aged 16-50 with developmental dysplasia of the hip. Eligibility is contingent upon meeting these prerequisites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

2018. "Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03481010.

All > Pathology